DEF: Applied DNA Sciences Seeks Shareholder Approval for Capital Structure Changes

Sentiment:

Proxy Statement


Applied DNA Sciences calls a Special Meeting to approve warrant exercises, increase authorized shares, and expand its equity incentive plan to support its new BNB digital asset strategy.

Capital raiseA private placement offering closed on October 22, 2025, involving the issuance of 6,888,382 pre-funded and common stock purchase warrants, generating gross proceeds of OBNB trust units valued at $11,710,000.If the warrant exercise proposal is approved and all Crypto Warrants are exercised for cash, the Company would receive approximately $13,157,000.The proposal to increase authorized common stock from 200,000,000 to 500,000,000 shares is explicitly for fundraising and capital accumulation to support the BNB Strategy, which 'may require significant additional capital, which would come primarily from the sale of the Company's common stock.'The BNB Strategy relies on a 'premium flywheel strategy' where the Company issues new shares to fund the acquisition of additional BNB when its stock trades at a premium to its Net Asset Value (NAV).

Summary

  • A Special Meeting of Stockholders will be held virtually on Friday, December 12, 2025, at 11:00 a.m. Eastern Time.
  • Stockholders will vote on three key proposals: (i) approval of the exercisability of 6,888,382 pre-funded and common stock purchase warrants issued in a private placement that closed on October 22, 2025, as required by Nasdaq Listing Rules 5635(a) and 5635(d); (ii) approval of an amendment to the Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 500,000,000; and (iii) approval of an amendment to the Company's 2020 Equity Incentive Plan to increase the number of authorized shares reserved for issuance by 5,000,000 shares.
  • The private placement offering, which closed on October 22, 2025, involved the issuance of 3,444,191 pre-funded warrants and 3,444,191 Series E-2 warrants, generating gross proceeds of OBNB trust units valued at $11,710,000 as of October 20, 2025.
  • If the warrant exercise proposal is approved and all Crypto Warrants are exercised for cash, the Company would receive approximately $13,157,000.
  • The increase in authorized shares is primarily to support the Company's new 'BNB Strategy,' which focuses on managing digital assets, primarily Binance Coin (BNB), through staking, restaking, and other yield opportunities, requiring significant additional capital from stock sales.
  • The amendment to the 2020 Equity Incentive Plan is deemed critical for attracting and retaining key talent in the competitive digital asset industry, as only 377 shares remained available for issuance under the current plan as of October 31, 2025.
  • As of October 31, 2025, there were 4,354,782 shares of Common Stock outstanding; if all Crypto Warrants are exercised, the Company would have 20,533,550 shares of Common Stock outstanding.
  • The Company recently implemented a restructuring plan, reducing its workforce by approximately 60% (16 employees), expecting pre-tax charges of $1,400,000 and annualized cost savings of $2,900,000.

Sentiment

Score: 6

Explanation: The filing outlines strategic shifts and necessary corporate actions to support a new digital asset strategy. While these actions are presented as crucial for future growth and flexibility, they also involve significant potential dilution and a pivot into a highly competitive and volatile industry. The restructuring and executive changes indicate a period of transition. The proposals are necessary for the company's stated future direction, but the financial performance (net loss, declining TSR) and the need for substantial capital raises introduce uncertainty.

Positives

  • The virtual meeting format is expected to increase stockholder attendance and participation while achieving cost savings for the Company.
  • The BNB Strategy aims to increase the overall value of the Company to its stockholders through expanded digital asset holdings and yield opportunities.
  • Increasing authorized shares provides greater flexibility for future fundraising, corporate development initiatives (such as strategic acquisitions or partnerships), and maintaining strategic agility in the dynamic digital asset market.
  • The ability to issue new shares can support liquidity and financial stability, allowing the Company to address financial needs and capitalize on future opportunities.
  • Expanding the equity incentive plan is critical for attracting and retaining key talent and directors in the highly competitive digital asset industry, aligning employee interests with shareholders.
  • A recent restructuring plan is expected to result in annualized cost savings of approximately $2,900,000.

Negatives

  • Future issuances of common stock will dilute existing stockholders' ownership, earnings per share, voting power, and other interests.
  • The issuance of authorized but unissued stock could potentially be used to deter a takeover that might otherwise be beneficial to stockholders.
  • Without approval of the increase in authorized shares, the Company's ability to effectively pursue its BNB Strategy will be limited.
  • Without approval of the Plan Amendment, the Company will be unable to continue granting equity awards, potentially leading to loss of employees, difficulties in recruiting new talent, and increased reliance on cash-based compensation.
  • The Company incurred estimated pre-tax charges of approximately $1,400,000 in connection with the reduction-in-force as part of its restructuring plan.
  • The Company reported a net loss of $7,088,000 and revenues of $3,431,000 for the fiscal year ended September 30, 2024.
  • Cumulative total shareholder return (TSR) was $99.93 for 2025 and $66.31 for 2024, indicating a decline in shareholder value.

Risks

  • Dilution of stockholders' ownership, voting power, and earnings per share due to the issuance of shares upon warrant exercise and future capital raises.
  • The potential for authorized but unissued stock to be used as an anti-takeover defense, which may not always align with stockholder interests.
  • Limitations on the Company's ability to pursue its BNB Strategy if the increase in authorized shares is not approved by stockholders.
  • Risk of losing key employees and difficulty in recruiting new talent if the amendment to the 2020 Equity Incentive Plan is not approved, potentially leading to increased reliance on cash compensation.
  • The estimated charges and cost savings from the restructuring plan are subject to assumptions, and actual results may differ, with potential for additional unforeseen costs.
  • The exercisability of the Crypto Warrants is contingent on stockholder approval, meaning they currently have no value without it.
  • The valuation of OBNB trust units received in payment for Crypto Warrants potentially resulted in an issuance price below the Nasdaq Minimum Price, triggering Nasdaq Listing Rule 5635(d) approval requirement, highlighting potential valuation complexities in digital asset transactions.

Future Outlook

The Company is strategically pivoting to primarily focus its resources on a 'BNB Strategy,' which involves managing digital assets, primarily Binance Coin (BNB), through staking, restaking, liquid staking, and participation in other Binance ecosystem yield opportunities. This new strategy is anticipated to require significant additional capital, primarily sourced from the sale of the Company's common stock. Management expects to recruit additional new employees and Directors from the highly competitive digital asset industry to support the further implementation of this strategy.

Management Comments

  • "We are pleased to use the latest technology to increase access, to improve communication and to obtain cost savings for our stockholders and the Company. Use of a virtual meeting will enable increased stockholder attendance and participation as stockholders can participate from any location." Clay D. Shorrock, President and Chief Executive Officer.
  • "Although such issuance of additional shares with respect to future financings would dilute existing stockholders, management believes that such transactions would increase the overall value of the Company to its stockholders through further implementation of the BNB Strategy."
  • "We recognize the dilutive impact that our equity compensation program has on our stockholders and continuously strive to balance this concern with the competition for talent in the competitive business environment and talent market, as well as the current market conditions, in which we operate."
  • "Maintaining our current equity compensation program is particularly critical at this time when competition for quality personnel is intense in the highly competitive digital asset treasury marketplaces in which we operate, and our ability to successfully execute, compete and deliver value to stockholders could be significantly negatively impacted if we cannot maintain our current equity award practices in support of retaining and attracting key talent."

Industry Context

The Company is undergoing a significant strategic shift, moving to primarily focus on a 'BNB Strategy' within the digital asset industry. This involves active management of cryptocurrency assets, specifically Binance Coin (BNB), and participation in the broader Binance ecosystem for yield generation. This pivot indicates a move away from or a significant reduction in previous business lines, as evidenced by recent divestments and a substantial workforce reduction. The Company acknowledges the 'highly competitive digital asset industry' and 'digital asset treasury marketplaces,' suggesting an entry into a rapidly evolving and potentially volatile sector that demands specialized talent and flexible capital structures.

Comparison to Industry Standards

  • The filing highlights the 'highly competitive digital asset industry' and 'digital asset treasury marketplaces' as the new operational environment, but does not provide specific comparable companies, projects, or results for direct assessment against global benchmarks.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman and Chief Executive OfficerDr. James HaywardJudith MurrahJune 18, 2025Dr. Hayward's retirement.
PresidentDr. James HaywardJudith MurrahDecember 13, 2024Dr. Hayward stepped down from the role.
President of LineaRx, Inc. (subsidiary)N/AClay ShorrockDecember 13, 2024Appointment to new role.
Chief Executive Officer and PresidentJudith MurrahClay ShorrockSeptember 29, 2025Ms. Murrah's resignation from the roles.
Chairperson of the BoardJudith MurrahJoshua KrugerNovember 6, 2025Ms. Murrah's resignation from the role.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Bylaws/Charter AmendmentProposed amendment to the Certificate of Incorporation to increase the number of authorized shares of common stock from 200,000,000 to 500,000,000.[ ] 2025 (upon filing, if approved)Enables future capital raises for the BNB Strategy, provides greater financial flexibility, but will result in significant potential dilution for existing stockholders and could have an anti-takeover effect.
Equity Plan AmendmentProposed amendment to the 2020 Equity Incentive Plan to increase the number of authorized shares of Common Stock reserved for issuance by 5,000,000 shares, bringing the total to 5,200,500 shares.Upon stockholder approval at the Special MeetingCritical for attracting and retaining key talent and directors in the competitive digital asset industry, aligning employee interests with shareholders, but will contribute to potential dilution.
Policy/ProcedureThe Board of Directors may, in its sole discretion, abandon the Proposed COI Amendment even if it is approved by stockholders, at any time before its filing effectiveness.N/AProvides the Board with ultimate control over the implementation of the authorized share increase, even after stockholder approval.
Policy/ProcedureThe 2020 Equity Incentive Plan (and the Amended Plan) does not contain an evergreen provision, meaning the share reserve does not automatically increase annually.N/ARequires explicit stockholder approval for future increases in the share pool, providing more direct stockholder oversight over equity compensation dilution.
Policy/ProcedureProhibition on repricing programs for options or stock appreciation rights without obtaining prior stockholder approval.N/AProtects stockholders from value erosion through repricing of equity awards without their consent.

Related Party Transactions

  • Joshua Kruger, appointed Chairman of the Board on November 6, 2025, is not an independent director. He is an affiliate of Cypress Management LLC and Cypress LLC, which provide services to the Company for compensation exceeding $120,000 annually. Mr. Kruger has approximately a 33% economic interest in each of these entities.
  • Mr. Kruger purchased 75,303 shares and 75,303 shares underlying warrants of the Company in the Private Placement.

Stakeholder Impact

  • **Shareholders**: Face potential significant dilution from the exercise of warrants and future stock issuances to fund the new BNB Strategy. Their voting power may also be diluted. However, they stand to benefit if the BNB Strategy successfully increases the overall value of the Company.
  • **Employees**: Experienced a workforce reduction of approximately 60% (16 employees) as part of a restructuring plan. The proposed expansion of the equity incentive plan is intended to attract and retain key talent, particularly for the new digital asset strategy, offering long-term incentives.
  • **Management**: Underwent significant changes in leadership roles, with new CEO and Chairman appointments. Current CEO and CFO received new employment agreements, including cash bonuses and stock options, aligning their compensation with strategic goals.
  • **Customers/Suppliers**: The strategic pivot to the BNB Strategy implies a shift in the Company's core business focus, which could lead to changes in existing customer and supplier relationships, though not explicitly detailed.
  • **Creditors**: The ability to issue new shares for capital raises could strengthen the Company's balance sheet or reduce debt, potentially benefiting creditors by improving financial stability.

Next Steps

  • Hold a Special Meeting of Stockholders on December 12, 2025, to vote on the proposed amendments.
  • If approved, the Company will file the Certificate of Amendment to increase authorized shares with the Secretary of State of Delaware.
  • If approved, the Plan Amendment will become effective, allowing for future equity awards to attract and retain talent.
  • Final voting results will be disclosed on a Form 8-K filed with the SEC within four business days after the Special Meeting.
  • The reduction-in-force from the restructuring plan is expected to be substantially completed by the end of October 2025, with associated charges recorded in the first quarter of fiscal 2026.
  • Ms. Murrah's lump sum payment of $400,000 is due on or before November 17, 2025.
  • Mr. Shorrock and Ms. Jantzen are to receive stock options with a grant-date fair market value of $200,000 each within seven days of their employment agreements' effective dates (September 29, 2025).
  • Stockholder proposals for the 2026 annual meeting must be received between January 22, 2026, and February 21, 2026.

Key Dates

DateDescription
December 13, 2024Dr. Hayward stepped down as President of the Company; Ms. Murrah was appointed President of the Company; Mr. Shorrock was named President of LineaRx, Inc.
December 7, 2024Ms. Jantzen's base salary was increased to $385,000.
November 25, 2024Base salaries for Ms. Murrah and Mr. Shorrock were increased to $400,000 and $385,000 respectively.
September 30, 2024Fiscal year end for the Company's 2024 Annual Report.
January 18, 2025Dr. Hayward reduced his annual base salary to $400,000.
June 16, 2025Dr. James A. Hayward informed the Company of his intention to retire.
June 18, 2025Dr. Hayward stepped down as CEO, Board member, and Chairman; Ms. Murrah was appointed Chairperson and CEO.
June 30, 2025Ms. Murrah voluntarily agreed to a 15% temporary reduction in her annual base salary to $340,000.
July 15, 2025First installment of Dr. Hayward's $450,000 separation payment due on or before this date.
August 10, 2025Company entered into an engagement agreement with the Placement Agent for the Offering.
September 9, 2025Placement Agent Agreement amended.
September 28, 2025Board approved the Plan Amendment (subject to stockholder approval); Board approved new Employment Agreements with Mr. Shorrock and Ms. Jantzen; Ms. Murrah informed the Company of her intention to step down as CEO and President.
September 29, 2025Company entered into securities purchase agreements with Cash Purchasers and Cryptocurrency Purchasers; Ms. Murrah stepped down as CEO and President, Clay Shorrock was appointed CEO and President; Ms. Murrah and the Company entered into a separation agreement.
September 30, 2025Fiscal year end for the Company's 2025.
October 1, 2025Current Report on Form 8-K filed with the SEC, referencing forms of Purchase Agreement, Pre-funded Warrant, and Series E-2 Warrant.
October 6, 2025Current Report on Form 8-K filed with the SEC, disclosing the restructuring plan.
October 17, 2025Mr. Shorrock and Ms. Jantzen were each granted 18,691 RSUs; each board member received 22,511 RSUs.
October 20, 2025OBNB trust units from the Cryptocurrency Offering were valued at $11,710,000.
October 22, 2025The Cryptocurrency Offering closed and the Crypto Warrants were issued.
October 29, 2025Market value of a share of Common Stock was $3.63.
October 31, 2025Record date for the Special Meeting; 4,354,782 shares of Common Stock outstanding; 19,157,363 outstanding warrants, 199,928 outstanding RSUs, 345 outstanding options; 377 shares remained available under the Current Plan.
November 6, 2025Ms. Murrah resigned as Chairperson; Joshua Kruger was appointed as Chairman of the Board and as a director.
November 10, 2025Proxy Statement was mailed to stockholders.
November 17, 2025Ms. Murrah's lump sum payment of $400,000 due on or before this date.
December 11, 2025Deadline for Internet and telephone voting (11:59 P.M. Eastern Time).
December 12, 2025Special Meeting of Stockholders to be held (11:00 a.m. Eastern Time).
March 23, 2026Deadline for stockholder notice of intent to solicit proxies for director election contest under universal proxy rule.
January 22, 2026Earliest date for stockholder proposals to be considered for inclusion in the 2026 annual meeting proxy statement.
February 21, 2026Latest date for stockholder proposals to be considered for inclusion in the 2026 annual meeting proxy statement.
December 15, 2026Webcast replay of the Special Meeting will be available until this date.
September 15, 2030The term of the 2020 Equity Incentive Plan will expire.

Recommendation

hold

The company is undergoing a significant strategic pivot into the digital asset space with its 'BNB Strategy,' which carries both high potential and high risk. The proposals for increasing authorized shares and expanding the equity incentive plan are necessary steps to fund this new direction and attract talent. However, the substantial potential for dilution, the inherent volatility of the cryptocurrency market, and the recent history of net losses and declining TSR suggest a cautious approach. While the restructuring aims for cost savings, the success of the new strategy is unproven. Investors should hold to observe the execution of the BNB Strategy and its impact on financial performance before making further commitments.

Keywords

Applied DNA Sciences, SEC filing, proxy statement, special meeting, stockholder approval, Nasdaq Listing Rules, private placement, warrants, common stock, authorized shares, Certificate of Incorporation, equity incentive plan, BNB Strategy, digital assets, cryptocurrency, OBNB trust, dilution, corporate governance, executive compensation, stock options, restricted stock units, Binance Coin

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.